Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$28,686,856
+$8,112,824 QoQ
Shares Held
527,235
+9.9% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#69
of 751 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Derivatives in EXEL
reported options exposure · as of Mar 31, 2026CallValue
$510,391
CallShares
11,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITAL FUND MANAGEMENT S.A. holds $326,278,392 across 42 Biotechnology names. EXEL ranks #4 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
155,904 | $46,931,781 | |
| 2 | INCY |
Incyte Corp
|
336,318 | $38,125,008 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
71,088 | $35,311,542 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
527,235 | $28,686,856 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
329,554 | $26,130,336 | |
| 6 | MRNA |
Moderna, Inc.
|
277,758 | $19,451,392 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
184,231 | $16,018,885 | |
| 8 | INSM |
INSMED Inc
|
148,976 | $15,883,821 |
All Filings in EXEL
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,686,856 | 527,235 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $20,574,032 | 479,693 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $510,391 | 11,900 | Call | Sole | 2026-05-14 | |
| 2025-12-31 | $547,875 | 12,500 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $499,662 | 11,400 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $28,703,916 | 654,892 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,827,173 | 528,503 | Shares | Sole | 2025-11-13 | |
| 2025-09-30 | $809,480 | 19,600 | Put | Sole | 2025-11-13 | |
| 2025-06-30 | $12,502,807 | 283,639 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,819,464 | 265,966 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,908,447 | 327,581 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,558,335 | 329,801 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,750,284 | 344,917 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,075,520 | 256,027 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,397,968 | 99,957 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $494,115 | 22,614 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $1,201,032 | 61,877 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,722,735 | 356,779 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,848,389 | 245,433 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,712,539 | 178,316 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,448,314 | 107,998 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,768,809 | 96,762 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,890,930 | 89,448 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $911,655 | 50,036 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $821,665 | 40,940 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,537,831 | 62,897 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,859,079 | 78,310 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $416,982 | 24,215 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||